All Posts By

Luciana Nofal

THANK YOU, SKIN OF COLOR UPDATE VIRTUAL 2020 SPONSORS

By | Skin of Color Update

NEW YORK, (August 25, 2020) – Luciana Halliday Nofal, VP Marketing and Client Relations SanovaWorks

Skin of Color Update Virtual 2020

This year, due to the global pandemic, for the first time, we are hosting Skin of Color Update 2020, virtually. Even though we will miss seeing everyone in person, we are committed to the health and safety of our employees, clients, and other support staff required to run a live event. We appreciate all the effort that it takes to change direction and to make such an important and impactful event happen. We are deeply grateful.

SanovaWorks would like to recognize Skin of Color Update Virtual 2020 supporters

Aveeno®

At Aveeno®, everything is rooted in our belief that balance is the key to wellbeing. That’s why we use groundbreaking science to transform nature’s ingredients into products that rebalance and renew your skin.

Allergan Aesthetics 

At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Learn more: www.AllerganAesthetics.com.

GALDERMA

Given the important role our skin plays in each of our daily lives, Galderma’s focus on science-based solutions for skin health is the way we seek to enhance the quality of people’s lives.

Journal of Drugs in Dermatology

The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology.

L’Oréal Group Dermatological Brands – CeraVE, La Roche-Posay, Skinceuticals, Dermablend

At L’Oréal, we share a common purpose to:  Create the beauty that moves the world.

CeraVe

In 2005, CeraVe’s dermatologists developed a line of skincare products enriched with a blend of three essential ceramides (ceramides 1, 3, and 6-II), fatty acids, and other lipids to help repair and strengthen the skin’s natural barrier.

LA ROCHE- POSAY

Recommended by 90,000 dermatologists worldwide, La Roche-Posay skincare is formulated with high efficacy and safety standards in a full range of products to address skin needs, even sensitive skin.

SKINCEUTICALS

Made in the USA, our clinical skincare is used by dermatologists, plastic surgeons, and medi-spas for daily homecare and to complement aesthetic procedures.

Dermablend

The choice to wear makeup is a powerful one – Dermablend Professional wants to strip away the judgement associated with this choice.

LEO Pharma

Leo Pharma has a 100+ year history as a specialty pharmaceutical company, committed to the discovery and development of novel drugs for patients.

Lumenis

Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF).

Neutrogena®

Neutrogena® the #1 Dermatologist Recommended skincare brand offers a wide range of skin and hair care products.

Regeneron/Sanofi

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. As the specialty care global business unit of Sanofi, our work is focused in the areas of rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.

PCA Skin

PCA SKIN is the innovator of the modified and enhanced Jessner’s peel and over the past decades our line of blended chemical peels has expanded to include treatment options for all skin types, ethnicities and conditions.

Sciton

Sciton was created to provide advanced lasers and light sources to the aesthetic medical markets. With over a decade of performance behind us, Sciton systems have become the standard of care in each application our products address.

Senté

Founded by biotech entrepreneurs and scientists, SENTÉ® is driven by a sense of wonder and scientific discovery. Our mission is to challenge beliefs and the status quo within the skincare industry.

Pfizer

Our purpose is grounded in our commitment to fund programs that provide public benefit, advance medical care and improve patient outcomes. Our belief is that all people deserve to live healthy lives. This drives our desire to provide access to medicines that are safe, effective, and affordable.

ODAC

ODAC Dermatology, Aesthetic and Surgical Conference (ODAC) is a distinguished ACCME accredited dermatology conference designed to meet the needs of medical and aesthetic dermatology providers in the 21st century.

 

This live virtual and enduring continuing education activity is supported through independent medical education grants provided by:

Allergan

Galderma Laboratories, L.P

Novartis Pharmaceuticals Corporation

Sanofi Genzyme and Regeneron Pharmaceuticals

UCB, Inc.

Sponsorships available Skin of Color Update 2020 Virtual

Through grant support, sponsorship & exhibitor opportunities:

  • Gain direct access to 300+ dermatology experts and influential faculty on our virtual platform
  • Increase your brand equity with this elite group of dermatology physicians through webinar product forums
  • Showcase your medical products, aesthetic treatments and device technology on our virtual event platform, through virtual product forums and more
  • Generate leads and expand your network with this niche group in the sponsor and exhibitor marketplace gallery
  • Expand your reach with an outflow publication in the Journal of Drugs in Dermatology (JDD)

Email [email protected] to become a Skin of Color Update Virtual Supporter.

Space is limited and sponsorship is not guaranteed. 

Luciana Halliday Nofal
VP of Marketing and Client Relations 

COVID 19: URGENT MEDICAL AND AESTHETIC ISSUES FOR DERMATOLOGY

By | Press

NEW YORK, (April 10, 2020) – Luciana Halliday Nofal, VP Marketing and Client Relations SanovaWorks

Polling Questions Answered by Dermatologists and Dermatology Healthcare Practitioners

Moderated by Joel L. Cohen, a panel of dermatologist and dermatology industry experts including Adam Friedman, MD, Neal Bhatia, MD, Bill Humphries (Ortho Dermatologist), Sue Ellen Cox, MD, Kavita Mariwalla, MD and Carrie Strom (Allergan) joined the COVID-19 conversation discussing the questions that are on the minds of many dermatologists and healthcare practitioners in the country. The initial broadcast attracted 1,900 registrants and nearly 800 attendees participated. More than 85% of the audience were of dermatology physicians, with the remaining participants made up of dermatology residents, fellows, nurse practitioners and physician assistants.  Attendees were polled a variety of questions regarding how their practice was responding to COVID-19.

Adoption of Teledermatology

Regarding how physicians were adapting to the use of teledermatology, almost one third (30.71%) of those who answered saw no teledermatology patients in the preceding week, almost forty percent (39.98%) saw less than five per day, under ten percent (9.06%) saw more than 11 patients a day, with the remainder of respondents (21.26%) saw between five and ten patients per day in the previous week.

When asked the average time a teledermatology encounter takes (physician log on to physician log off), almost one third (31.25% said five to ten minutes, almost half (47.12%) took from eleven to twenty minutes, less than four percent (3.85%) took more than thirty minutes for the encounter, while the remaining (17.79%) took twenty-one to thirty minutes.

Urgent Dermatologic Cases

When the subject of what urgent dermatologic cases besides melanoma the participating dermatologists were seeing live in their practice, almost one third (29.41%) answered “zoster, versus concerning rash”, more than forty percent (41.18%) answered “spot checks of atypical pigmented lesions”, just over a quarter (26.47%) were seeing “invasive growing squamous cell” and under three percent (2.94%) were seeing live patients in their office for tumors around the orbit.

Patient Access to Medications

Almost one half of those who responded (47.85%) answered that they were having difficulty getting anti-malarials (HCQ, Chloroquine) for their patients that are on them, while the other half (52.15%) were not.

Return to Business for Cosmetic Practices 

Almost forty percent of those polled (38.69%) were optimistic that their practice would be back to “normal” (seeing cosmetic patients full time) in July, with an almost even spread of the remainder of respondents believing their practice would be back to normal in June (16.58%), August (15.58%), September (14.57%) or October and beyond (14.57%).

Planning for the year ahead

When asked how likely participants were to register now for a conference taking place in the fall, winter or spring, the majority of those who answered, said they were likely to register now for meetings during any of those time frames, ranging from almost half of respondents (47.75%) who would be likely to register now for a fall meeting, almost two-thirds (62.64%) for a meeting in the winter, and more than three-quarters (77.78%) would register now for a meeting taking place in the Spring. 

We look forward to asking more questions in the future to help the community provide the support it needs right now.

The on-demand broadcast has attracted over 500 registrants as of April 9th and is available on JDDonline.com.

Click here for access to Part I

Part II:  COVID-19: Your Questions Answered

COVID-19: Your Questions Answered, part II of the webinar series, was broadcasted on April 7, 2020. 

During this webinar dermatology experts and other thought leaders examined the legal and financial concerns of dermatology providers during the global coronavirus pandemic. David Goldberg, MD, JD lead a panel of experts, Joel L Cohen, MD, Jeffrey Dover, MD, Gunga Mukkavilli, CPA, and Janel Ablon, Esq. through discussions on furlough vs. layoffs; mortgage and rent relief programs; the CARES Act; and other important and current legal and financial matters for dermatologists. 

A second panel of experts including Joel L Cohen, MD and Jeffrey Dover, MD, from the previous panel, joined by Elizabeth Tanzi, MD, and moderated by Adam Friedman, MD, answered questions, discussed practical tips you can use in your practice right now; and how to move forward with patient care. Part II attracted 1,300 registrants with nearly 700 attendees.

Staffing, financials, and teledermatology

Over half of those polled (53.42%) responded that since the pandemic they have had to furlough staff and almost one quarter (23.6%) hadn’t but believed they may have to in the future. 

More than three-quarters of respondents (75.46%) said that their receivables in March compared to February are decreased greatly, while less than eight percent said their receivables were “about the same” (5.52%) or had “increased slightly” (2.45%). The remainder of respondents (16.56%) indicated that their receivables had decreased slightly.

With regards to financial assistance programs, almost all respondents (89.15%) said that they applied for the Paycheck Protection Program a Small Business Association loan that helps businesses keep their workforce employed during the COVID-19 crisis. In addition to this, almost one third (28.68%) had applied for the EIDL (Economic Injury Disaster Loan Emergency Advance), just under eight percent (7.75%) had applied for other Federal loans or grants, six percent (6.2%) applied for state loans or grants, and just two percent (2.33%) had found and applied for other loans or grants. 

Most respondents (78.42%) were not planning on borrowing from their retirement savings, while a further almost twenty percent (18.42%) were unsure and just three percent (3.16%) indicated they were planning on borrowing from their retirement fund,

Only a very small number of those polled (8.84%) feel experienced with teledermatology and use it as a normal part of their practice, and less than five percent (4.42%) were not planning on using it at all. Almost all respondents (86.74%) had little to no experience in teledermatology. Almost sixty percent (58.01%) had started teledermatoligy since the pandemic began, a further twenty percent (21.55%) had started before the pandemic but considered themselves a beginner, and a further seven percent (7.18%) had not started but wanted to.

We hope you enjoy watching and listening to these panels of experts discuss the latest issues in dermatology and we look forward to bring you more episodes.

The on-demand broadcast of Part II will be available on April 11, 2020 on JDDonline.com.

Click here for Part II

SANOVAWORKS COVID-19 RESOURCES

 

SANOVAWORKS COVID-19 RESOURCES

By | Press

NEW YORK, (Apr. 9th, 2020) – Luciana Halliday Nofal, VP Marketing and Client Relations

In response to the needs of the SanovaWorks community, our brands have developed COVID-19 resources.

COVID 19 part I dermatology JDD Next Steps SanovaWorks

On April, 1, 2020, the Journal of Drugs in Dermatology (JDD) and SanovaWorks brands launched Part I of the webinar series: COVID-19: Urgent Dermatology and Aesthetic Issues for Dermatology.

Over the course of the 2 hours, Joel L. Cohen, MD and 6 different thought leaders joined the COVID-19 conversation, discussing the pressing questions that are on the minds of many dermatologists and providers in the country. The initial broadcast attracted 1,900 registrants and nearly 800 attendees comprised of physicians, residents, fellows, nurse practitioners and physician assistants.  Attendees were interested and engaged throughout the entire 2 hours with a 76% average attentiveness and 72% average interest rating.

The on-demand broadcast has attracted over 500 registrants as of April 9th and is available on JDDonline.com.

Part II COVID in Dermatology Webinar Financial and Legal

On April 7, 2020, Part II of the webinar series was broadcasted: COVID-19: Your Questions Answered. Dermatology experts and thought leaders examined the legal and financial concerns of dermatology providers during the global coronavirus pandemic. Experts discussed furlough vs. layoffs; mortgage and rent relief programs; the CARES Act; the pros and cons of leveraging NPs or PAs for teledermatology and more. Then, hear questions answered by our panel of experts; discussed practical tips you can use in your practice right now; and how to move forward with patient care. Part II attracted 1,300 registrants with nearly 700 attendees. Attendees were engaged and interested throughout with an 82% attentiveness average and 75+% interest rating.

The on-demand broadcast of Part II will be available on April 11, 2020 on JDDonline.com.

Next Steps in Dermatology, a resource for young dermatologists and residents, recently launched a COVID-19 News and Resource Center. Next Steps in Derm COVID-19 News & Resources Center offers a curated selection of relevant news and resources from truthworthy sources to help physicians navigate the COVID-19 pandemic.

Resources include:

  • COVID-19 Webinars
  • Free CME
  • COVID-19 Related Podcast Episodes
  • COVID-19 PubMed Articles in JAAD, JDD, etc.
  • Recommendations from AAD, AMA, etc.
  • Guidance from HIPAA, Medicare, and on Telehealth
Friedman Dermatologist ODAC disaster preparedness

ODAC AND JDD HELP IDENTIFY NEED FOR DISASTER TRAINING AMONG DERMATOLOGISTS

By | ODAC, Press

A new study from the George Washington University found that many dermatologists are unprepared to respond to biological disasters and that the specialty would benefit from formal preparedness training.

WASHINGTON (Jan. 30, 2020) — The dermatology community is inadequately prepared for a biological disaster and would benefit from a formal preparedness training program, according to a study from the George Washington University (GW). The article is published in the Journal of Drugs in Dermatology.

Natural and man-made disasters can cause a range of dermatologic conditions due to environmental exposures, such as secondary infections following a flood, irritation from blistering agents used in chemical warfare, and acute and chronic effects of cutaneous radiation syndrome. A 2003 survey revealed that 88% of dermatologists felt unprepared to respond to a biological attack — this new survey shows that the need for training still exists.

“Recognizing and diagnosing the conditions that can arise following a disaster requires diagnostic acumen, knowledge on reporting, and short- and long-term management strategies,” said Adam Friedman, MD, interim chair of the Department of Dermatology at the GW School of Medicine and Health Sciences and senior author on the study.

This current survey from an interdisciplinary team of dermatology and emergency medicine researchers, led by Emily Murphy, a research fellow in the GW Department of Dermatology, examines whether the field of dermatology has advanced in its bioterrorism preparedness.

The survey, disseminated via the ODAC Dermatology, Aesthetic & Surgical conference listserv, found that only 28.9% of respondents received training in disaster preparedness and response. The respondents to the survey frequently commented that they felt dermatologists should be prepared for bioterrorism-related cutaneous diseases, such as anthrax or smallpox-related diseases, as well as infections resulting from natural disasters.

Similar to the 2003 survey, the authors found that few dermatologists received adequate bioterrorism preparedness training. Even among those who had reported training, many indicated they felt ill prepared to manage patients affected by disasters, especially biological attacks and nuclear or radiological events.

“While few respondents to the survey were trained in disaster preparedness, it is encouraging that 75% reported that it should be included in dermatology training,” Friedman said. “It is a necessary tool to advance the field.”

James Phillips, MD, section chief of disaster and operational medicine in the GW Department of Emergency Medicine, director of the GW Disaster Medicine Fellowship, and co-author on the study, agreed: “My fellows and I found great value in partnering with our dermatology colleagues for this project. It is my firm belief that, while disaster medicine and emergency management primarily fall within the scope of emergency medicine and trauma surgery, education, and training for other specialties is of great value and is virtually unexplored. In an increasingly complex disaster environment, we welcome such research collaborations with other GW specialists.”

###

The article, titled “A Survey of Dermatologists’ Preparedness for Natural and Man-made Disasters,” is published in the Journal of Drugs in Dermatology and can be found at jddonline.com/articles/dermatology/S1545961620P0016X/1.

Susan Weinkle ODAC Award

ODAC VICE CHAIR SUSAN WEINKLE, MD RECOGNIZED AS OUTSTANDING EDUCATOR & MENTOR

By | ODAC, Press

ORLANDO, Fla. (Jan. 21, 2020) – The ODAC Dermatology, Aesthetic & Surgical Conference, in partnership with the Journal of Drugs in Dermatology (JDD), honored dermatologist Susan H. Weinkle, MD, with the Outstanding Educator & Mentor in Dermatology Award at the conference held January 17-20 in Orlando, Fla.

The award recognizes individuals who have demonstrated a long-standing commitment to educating and mentoring the next generation of dermatologists, and who have devoted a major portion of his or her professional life to enhancing the practice and profession of dermatology through education.

“It is a pleasure and an honor to recognize the tireless work of exceptional leaders in dermatology,” said Shelley Tanner, CEO and president of SanovaWorks, which produces the JDD, ODAC, Derm In-Review and Next Steps in Dermatology. “Not only do these dermatology leaders dedicate their entire lives to benefiting patients every day, but after the “work day” ends, they spend countless hours involved in activities to improve the specialty’s future. We congratulate Dr. Weinkle for being chosen for this award.”

“Physicians around the globe have learned so much from Dr. Susan Weinkle,” said dermatologist and ODAC vice conference chair Joel Cohen, MD. “Susan has given all of us in aesthetics so much of her time and energy, and I am honored to present this award to her.”

Dr. Weinkle is an assistant clinical professor of dermatology at the University of South Florida, Tampa, Fla. She is a past president of the Women’s Dermatological Society and the American Society for Dermatologic Surgery. In addition, Dr. Weinkle is a former committee chair and member of the board of directors of several dermatology organizations, including the American Academy of Dermatology, Dermatology Foundation, and Florida Society of Dermatology and Dermatologic Surgery. Dr. Weinkle is in private practice in Bradenton, Fla., specializing in Mohs Micrographic Surgery and cosmetic dermatology. Her daughter, Allison, will join the practice upon completion of her dermatology residency and fellowships in cosmetic dermatology and Mohs Micrographic Surgery.

The recipient of the Outstanding Educator & Mentor in Dermatology Award, given by the Journal of Drugs in Dermatology, is nominated and chosen through the recommendation of a panel of senior national thought-leaders in dermatology, a committee of dermatology practitioners and several industry leaders.

 

Skin of Color update on-demand online videos

SKIN OF COLOR UPDATE ON-DEMAND

By | Skin of Color Update

NEW YORK (Dec. 4, 2019) – Skin of Color Update, a product of SanovaWorks, has launched an on-demand video package that expands the program’s reach. The highest attendee-rated sessions from Skin of Color Update 2019 are now available as online videos as part of the “Best of Skin of Color Update” package. Skin of Color Update is the largest continuing education event dedicated to trending evidence-based research and new practical pearls for treating skin types III – VI.

“We are humbled and honored that our Skin of Color Update conference has been consistently sold out,” said Skin of Color Update co-chair and founding dermatologist Eliot Battle, MD. “It’s vital for every dermatologist to know how to safely and effectively treat skin of color. As such, Skin of Color Update is moving to a larger venue next year, and dermatologists who are unable to attend in person can now access lecture material on their computers.”

On-demand lectures include:
• “Pearls for the Diagnosis and Treatment of Atopic Dermatitis and Eczema” with Andrew Alexis, MD, MPH
• “Complex Medical Cases” with Andrew Alexis, MD, MPH, and Ted Rosen, MD
• “Surgical Approaches for Keloids” with Maritza Perez, MD
• “Hair & Scalp Disorders Treatment Strategies: What, How and When?” with Heather Woolery-Lloyd, MD
• “Pearls and Strategies for Preventing Laser Complications” with Eliot F. Battle, Jr., MD.

Each video is in-sync with slides and audio. The content focuses on expert techniques, real-life clinical cases and expert pearls immediately useful in practice.

Skin of Color Update Dermatology On-Demand

 

 

 

 

The “Best of Skin of Color Update” package is available by clicking the On-Demand tab at SkinofColorUpdate.com.
Skin of Color Update is a product of SanovaWorks, publisher of the Journal of Drugs in Dermatology (JDD) and producer of the ODAC Dermatology, Aesthetic & Surgical Conference.

Sanovaworks JDD oral Collagen New York Times

SANOVAWORKS JDD ARTICLE CITED IN NEW YORK TIMES

By | Press

NEW YORK (Nov. 19, 2019) – Oral Collagen Supplements: Are they Fountain of Youth or Snake-oil? The New York Times cites SanovaWorks publication, the Journal of Drugs in Dermatology (JDD).

In January 2019, the JDD (Journal of Drugs in Dermatology) published “Oral Collagen Supplementation: A Systematic Review of Dermatological Applications” published a literature review and analysis of eleven scientific studies that all met defined criteria. All studies included in the review were considered “randomized-controlled studies” lending weight to their voice. The study concluded that results were optimistic for both short and long-term use of oral collagen supplements for wound healing and skin aging. Additionally, skin elasticity, hydration and collagen density were seen to increase with use. The authors of the study cited that collagen supplementation was generally safe with no reported adverse events however advised that further studies were required to provide better clinical guidelines for the use of collagen. SanovaWorks blog for young dermatologists and residents, Next Steps in Derm, provides a summary of the JDD article here.

Collagen is a protein that makes up approximately 80% of our skin and yet declines in volume at a rate of about 1% annually from our 20’s, says Dr. Whitney Bowe, a board-certified dermatologist. The question is, can you replenish your skin and youthful look through applying additional collagen on your skin or consuming similar supplements? The New York Times took a closer look at this subject citing JDD article.

You can find the New York Times article here: https://www.nytimes.com/2019/11/09/style/self-care/collagen-benefits.html

Dr. Bowe believes that the studies, “though small and preliminary,” show promise. Dr. Bowe has begun recommending oral collagen to her patients and has observed noticeable positive changes in skin elasticity, firmness and hydration.

“With volume of information available to the consumer it is imperative that independent scientific studies continue to be conducted and reported on to protect the consumer and patient. This is what we strive to do with the JDD” says Shelley Tanner, President of SanovaWorks, publisher of JDD (Journal of Drugs in Dermatology).

Sanova Works SanovaWorks launches Derm In-Review

SANOVAWORKS LAUNCHES NEW DERM IN-REVIEW STUDY TOOLS

By | Derm In-Review, Residents

NEW YORK, NY (Nov. 1, 2019) – SanovaWorks launches new Derm In-Review Study Guide and Online Image Companion free for dermatology residents and dermatology professionals.

Emerging and established academic leaders from all of the various fields within dermatology have come together to redesign and update the most comprehensive study guide and online image companion in dermatology board review. Derm In-Review’s 2019/2020 study guide and online image companion match the new and pending changes to examinations that lay ahead for dermatology residents. Changes include clinical guidelines, high-def, high-quality digital images and delineation of information appropriate for the Basic, Core and Applied exams as outlined in the Exam of the Future.

Study Guide Updates

The Derm In-Review study guide is over 400 pages and formatted for quick study and easy reference. It includes call-out text, tip boxes, highlighted text, mnemonic boxes and 300+ full-color images.  The study guide is comprised of five chapters:

Chapter 1: Basic Science (including Immunodermatology)

Chapter 2: Medical Dermatology

Chapter 3: Pediatric Dermatology

Chapter 4: Surgical Dermatology

Chapter 5: Dermatopathology

Request or Download the Study Guide

2019/2020 Derm In-Review study guides will be provided to all US dermatology residents in print. A free electronic version of the study will also be available for download on the Derm In-Review website. Log in or create a complimentary account and then go to Study Guide Request in your dashboard. Special thanks goes to the Derm In-Review advertisers and corporate sponsors: Aurora Diagnostics, Celgene, Lilly, and Novartis.

In addition, all of the study guide clinical images as well as additional clinical images will be available in the Online Image Companion.  This companion includes nearly 400 original images and will allow users to log on to the website to enlarge the images for enhanced viewing.  Over 100 images are dedicated to dermatopathology board review.

Exam of the Future

The American Board of Dermatology (ABD) is restructuring the In-Training and Certification exams—moving from our current approach of emphasizing knowledge retention and visual diagnosis to exams that better emphasize the application of knowledge using clinically relevant case scenarios. The Exam of the Future will be a staged evaluation with a BASIC exam designed for first-year residents, covering dermatology fundaments; CORE exam modules testing more advanced knowledge of senior residents about dermatology’s major clinical areas; and an APPLIED exam given after residency, which tests the ability to apply knowledge in clinical situations.

Visit the Derm In-Review website for more information.  If you would like to advertise or support Derm In-Review, please reach out to Luciana Nofal at [email protected].  Derm In-Review is a produced and published by SanovaWorks.

 

 

MOC CertLink ODAC Dermatology

DR. STRATMAN TO PRESENT MOC CERTLINK AT ODAC

By | ODAC

NEW YORK (Oct. 30, 2019) – Erik J. Stratman, MD, 2019 President of the American Board of Dermatology (ABD), to present on Maintenance of Certification (MOC) CertLink in January at ODAC Dermatology, Aesthetic and Surgical conference.

Changes to MOC

A major shift in continuing certification is coming for board-certified dermatologists in January. Erik J. Stratman, MD will present, “Changes to Your MOC Requirements: What Every Dermatologist Should Know about CertLink,” on January 17th, 2020 at the J.W. Marriot in Orlando, Florida.

Workshop Description

Dr. Stratman will walk-through the CertLink® MOC program and demonstrate its design, rationale and navigation. According to the ABD, CertLink provides the utmost flexibility in MOC and provides an alternative to the one-time, sit-down, high stakes in-person MOC examination. Dermatologists will be able to go online and take test questions in the convenience of their own home or office at various times throughout the year.

ABD MOC CertLink®

CertLink® is a longitudinal testing platform. The platform is designed to test and build medical knowledge in a “test to competence” type model.  In addition, CertLink® will keep dermatologists up to date by providing the latest articles from dermatology subspecialties. CertLink™ assessment platform is powered by American Board of Medical Specialties (ABMS).

Registration and Fees

The pre-conference workshop is provided complimentary for dermatologists registered for ODAC 2020.

About ODAC

Attend ODAC to stay connected, informed, and up-to-date in dermatology. ODAC (previously Orlando Derm) is one of the largest and most prestigious conferences of the year. ODAC attracts a national audience of over 650 US Dermatology Physicians, Dermatology Residents, Nurse Practitioners and Physician Assistants.

Visit orlandoderm.org to register for ODAC and attend this workshop.  ODAC is a product of SanovaWorks.

 

 

ODAC Dermatology Sold Out Hot Topics

ODAC OFFERS MORE ACCESS TO HOT TOPICS

By | ODAC, Press

New York (Oct. 28, 2019) – The ODAC Dermatology, Aesthetic & Surgical Conference (ODAC) is extending its program for 2020 with additional time for ODAC hot topics, general sessions and workshops.

Attendee Feedback

“We’ve listened to our attendees and altered our program to provide greater access to the hottest topics in the field,” said Perry Robins, MD, dermatologist and founder of ODAC. “Our sessions are led by expert faculty who provide the latest research and clinical updates on a variety of medical, surgical and aesthetic dermatology topics.”

The 2020 conference will be held January 17-20 at the JW Marriott in Orlando, Florida. ODAC, which started in 2003, attracts more than 650 dermatology physicians, residents, nurse practitioners and physician assistants each year.

The 2020 conference focuses on clinical dermatology updates, new treatments, new uses for old treatments, new product lines, changes to therapeutic guidelines, and hot and controversial topics. The interactive learning experience includes more than 20 workshops and more than 5 hours of live aesthetic demonstrations. In addition, ODAC offers hands-on sessions, live Q&As and opportunities to dialogue with leaders in the field. Up to 31 AMA PRA Category 1 Credits™ are available.

One-of-a-Kind

“There is no other conference like ODAC,” said dermatologist and conference chair James Spencer, MD, MS. “Each presentation provides practical pearls you can implement in your practice. This will be my 17th ODAC, and this meeting keeps getting better and better.”

In addition, three pre-conference workshops are available the first day of the conference:

  • “Comprehensive Nonsurgical Aesthetic Rejuvenation” with Martin Braun, MD
  • “Maintenance of Certification Workshop (Self-Assessment Credit)” with Erik Stratman, MD
  • “Derm In-Review Board Review” with session chair and conference medical director Adam Friedman, MD (in partnership with George Washington University)

Additional Faculty

  • Joel L. Cohen, MD, vice conference chair
  • Susan H. Weinkle, MD, vice conference chair
  • Martin Braun, MD
  • Justin Finch, MD
  • Robert Gotkin, MD
  • Jeremy Green, MD
  • William Hanke, MD
  • John Harris, MD
  • Sima Jain, MD
  • Terrence Keaney, MD
  • Leon Kircik, MD
  • Yasmine Kirkorian, MD
  • Sailesh Konda, MD
  • Angelo Landriscina, MD
  • Kavita Mariwalla, MD
  • Amy McMichael, MD
  • Alan Menter, MD
  • David Miller, MD
  • Vishal Patel, MD
  • Desiree Ratner, MD
  • Victor Ross, MD
  • Deborah S. Sarnoff, MD
  • Linda Stein Gold, MD
  • Erik Stratman, MD
  • Jackie Yee, MD
  • Jonathan Zippin, MD

Attendees may visit the exhibit hall that showcases the latest innovations in dermatology by more than 70 companies. In addition, more than 80 research and case study posters are available for viewing. The Advanced Resident Training and Education (ARTE) scholarship program provides the ODAC learning experience to more than 100 future dermatologists.

ODAC is a product of SanovaWorks, publisher of the Journal of Drugs in Dermatology (JDD) and producer of the Skin of Color Update conference.

Registration is available at orlandoderm.org.